Howard B. Rosen

Insider Reports History

Location
C/O Acelrx Pharmaceuticals, Inc., 351 Galveston Drive, Redwood City, CA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard B. Rosen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. Director Common Stock 16.2K $56.5K $3.48 Jun 15, 2025 Direct
ACELRX PHARMACEUTICALS INC Director Common Stock 5.29K $3.85K $0.73 Oct 10, 2023 Direct
KALA BIO, Inc. Director Common Stock 262 $911 $3.48 Jun 15, 2025 Indirect
KALA BIO, Inc. Director Stock Option (right to buy) 5.45K Jun 15, 2025 Direct
ACELRX PHARMACEUTICALS INC Director Stock Option (Right to Buy) 3.49K Oct 10, 2023 Direct

Insider Reports Filed by Howard B. Rosen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Jun 15, 2025 2 $0 4 Jun 17, 2025 Director
KALA KALA BIO, Inc. Jun 11, 2024 2 $0 4 Jun 12, 2024 Director
ACRX ACELRX PHARMACEUTICALS INC Oct 10, 2023 2 $0 4 Dec 13, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 4 $0 4 Jun 23, 2023 Director
KALA Kala Pharmaceuticals, Inc. May 31, 2023 6 $0 4 Jun 2, 2023 Director
ACRX ACELRX PHARMACEUTICALS INC Jul 15, 2022 2 $0 4 Jul 15, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
ACRX ACELRX PHARMACEUTICALS INC Jun 17, 2021 2 $0 4 Jun 17, 2021 Director